Insight on Treating Early-Stage HER2+ Breast Cancer With NERLYNX

Tajuana Bradley, MS, FNP-BC, an advanced practice provider at Georgia Cancer Specialists in Atlanta, has experience managing and treating patients with HER2-positive breast cancer in the extended adjuvant setting. She discusses the roles and responsibilities of the healthcare team, provides experience in managing patients receiving NERLYNX® (neratinib), and shares best practices for helping her patients through the treatment cycle, including adverse events, lifestyle modifications, and more. Ms. Bradley encourages a steady stream of communication between the healthcare team and the patient to improve outcomes and reduce the patient’s physical and emotional burden. She offers advice for both patients and the healthcare providers who support them. Ms. Bradley earned her Master of Science – family nurse practitioner degree from Georgia State University in Atlanta and has received several awards for her work.